Petro Matad announces that on 24 July 2017 Dr Oyungerel Janchiv, non-executive director of Petro Matad, gifted for no consideration and by way of off-market transactions, 3,600,000 ordinary shares of US$0.01 each in the Company ("Shares") to her children Shinezaya Batbold and Dulguun Batbold, each of whom received 1,800,000 Shares.
Dr Oyungerel and Petrovis Matad Inc. ("Petrovis") are members of the Petrovis Group Concert Party. Dr Oyungerel controls more than 20% of Petrovis. Her direct holding in Petro Matad of 13,267,946 Shares (following the transactions detailed above) is, for disclosure purposes, aggregated with that of Petrovis under the AIM definition of director's family. The aggregated holding of Dr Oyungerel and Petrovis is 107,952,208 Shares representing 34.11 per cent. of the Company's issued share capital.
Following the above transactions, the combined shareholdings of the Petrovis Group (being Petrovis, its underlying shareholders and their family members) will remain unchanged at 144,112,822 Shares, representing 45.54 per cent. of the Company's issued share capital.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM